COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Sensors CDT seminars > Challenges and key considerations for integrating sensor technologies in medical devices and in vitro diagnostics
Challenges and key considerations for integrating sensor technologies in medical devices and in vitro diagnosticsAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Suzanne Boone. Register here: https://www.eventbrite.co.uk/e/industry-lecture-andrew-ede-co-founder-of-eg-technology-tickets-134267438523 The value of the global sensor market is projected to reach $287 billion by 2025. But with demand for reliable, high-performance, low-cost sensors increasing, and new technologies, such as microtechnology and nanotechnology being developed, we look at the challenges and key considerations throughout your development journey, when implementing your sensor technology in to a marketable medical device or IVD . This webinar will look at the various development challenges when working with Sensor Technologies. Starting with an overview of the different types of tech, from optical and electromagnetic to electrochemical and implantable, we will discuss how the benefits of novel sensor tech can be outweighed by the many pitfalls often found downstream in volume implementation. We will then move on to regulatory requirements and the necessity of identifying, assessing and overcoming the many risks in your development programme, as early as possible. This talk is part of the Sensors CDT seminars series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsWedding invitation Meeting the Challenge of Healthy Ageing in the 21st Century Cambridge Defend EducationOther talksEnvironmental exposures shape the immune system early in life The role of microbes and microbial metabolites in regulation of host responsiveness Dreams of Paradise mTOR signaling in growth and metabolism PP2A-B55 inhibitors Arpp19 and ENSA define the cell cycle program by controlling the temporal pattern of protein phosphorylation Mesoscale fMRI and electrophysiology in human visual cortex |